Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,105,000 | 1,000,000 | 615,000 | 671,000 | 537,000 |
| Marketable Securities | 437,000 | 263,000 | N/A | 81,000 | N/A |
| Receivables | 846,000 | 814,000 | 675,000 | 542,000 | 508,000 |
| Inventories | 314,000 | 279,000 | 302,000 | 281,000 | 247,000 |
| Income taxes - deferred | N/A | N/A | N/A | 245,000 | N/A |
| Other current assets | 321,000 | 318,000 | 397,000 | 0 | 218,000 |
| TOTAL | $3,023,000 | $2,674,000 | $1,989,000 | $1,880,000 | $1,510,000 |
| Non-Current Assets | |||||
| PPE Net | 839,000 | 814,000 | 787,000 | 744,000 | 692,000 |
| Investments And Advances | 645,000 | 510,000 | 527,000 | 558,000 | 469,000 |
| Intangibles | 3,327,000 | 3,333,000 | 2,465,000 | 2,461,000 | 2,471,000 |
| Other Non-Current Assets | 149,000 | 101,000 | 76,000 | 56,000 | 61,000 |
| TOTAL | $4,960,000 | $4,758,000 | $3,855,000 | $3,819,000 | $3,693,000 |
| Total Assets | $7,983,000 | $7,432,000 | $5,844,000 | $5,699,000 | $5,203,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,000 | N/A |
| Accounts payable and accrued liabilities | 934,000 | 696,000 | 570,000 | 78,000 | 73,000 |
| Accrued Expenses | N/A | N/A | N/A | 597,000 | 551,000 |
| Other current liabilities | 181,000 | 98,000 | 89,000 | 80,000 | 153,000 |
| TOTAL | $1,871,000 | $1,586,000 | $1,743,000 | $1,393,000 | $1,440,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,740,000 | 1,762,000 | 611,000 | 1,172,000 | 977,000 |
| Other Non-Current Liabilities | 109,000 | 112,000 | 271,000 | 121,000 | 211,000 |
| TOTAL | $2,107,000 | $2,142,000 | $882,000 | $1,444,000 | $1,188,000 |
| Total Liabilities | $3,978,000 | $3,728,000 | $2,625,000 | $2,837,000 | $2,628,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 844,477 | 842,168 | 835,084 | 833,118 | 819,156 |
| Common Shares | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 |
| Retained earnings | 2,494,000 | 2,235,000 | 1,928,000 | 1,789,000 | 1,725,000 |
| Other shareholders' equity | -55,000 | -44,000 | -72,000 | -49,000 | -64,000 |
| TOTAL | $4,005,000 | $3,704,000 | $3,219,000 | $2,862,000 | $2,575,000 |
| Total Liabilities And Equity | $7,983,000 | $7,432,000 | $5,844,000 | $5,699,000 | $5,203,000 |